Literature DB >> 25897155

Chimeric antigen receptor T cells for cancer immunotherapy.

Kevin J Curran1, Renier J Brentjens2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25897155     DOI： 10.1200/JCO.2014.60.3449

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  21 in total

Review 1.  Fast Cars and No Brakes: Autologous Stem Cell Transplantation as a Platform for Novel Immunotherapies.

Authors:  Miguel-Angel Perales; Craig S Sauter; Philippe Armand
Journal:  Biol Blood Marrow Transplant       Date:  2015-10-17       Impact factor: 5.742

Review 2.  Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR.

Authors:  Miguel-Angel Perales; Partow Kebriaei; Leslie S Kean; Michel Sadelain
Journal:  Biol Blood Marrow Transplant       Date:  2017-10-13       Impact factor: 5.742

Review 3.  Immunotherapeutic strategies for sarcoma: current perspectives.

Authors:  Xueyao Li; Gangyang Wang; Zhengdong Cai; Wei Sun
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

4.  Flow Cytometry-based Assay for the Monitoring of NK Cell Functions.

Authors:  Sara Tognarelli; Benedikt Jacobs; Nina Staiger; Evelyn Ullrich
Journal:  J Vis Exp       Date:  2016-10-30       Impact factor: 1.355

Review 5.  Opportunities and challenges for TCR mimic antibodies in cancer therapy.

Authors:  Aaron Y Chang; Ron S Gejman; Elliott J Brea; Claire Y Oh; Melissa D Mathias; Dmitry Pankov; Emily Casey; Tao Dao; David A Scheinberg
Journal:  Expert Opin Biol Ther       Date:  2016-04-27       Impact factor: 4.388

6.  Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia.

Authors:  Peter G Maslak; Tao Dao; Yvette Bernal; Suzanne M Chanel; Rong Zhang; Mark Frattini; Todd Rosenblat; Joseph G Jurcic; Renier J Brentjens; Maria E Arcila; Raajit Rampal; Jae H Park; Dan Douer; Laura Katz; Nicholas Sarlis; Martin S Tallman; David A Scheinberg
Journal:  Blood Adv       Date:  2018-02-13

Review 7.  Adoptive T Cell Therapies: A Comparison of T Cell Receptors and Chimeric Antigen Receptors.

Authors:  Daniel T Harris; David M Kranz
Journal:  Trends Pharmacol Sci       Date:  2015-12-17       Impact factor: 14.819

8.  CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape.

Authors:  David Pettitt; Zeeshaan Arshad; James Smith; Tijana Stanic; Georg Holländer; David Brindley
Journal:  Mol Ther       Date:  2017-11-02       Impact factor: 11.454

Review 9.  The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?

Authors:  Martin Dreyling; Simone Ferrero
Journal:  Haematologica       Date:  2016-02       Impact factor: 9.941

10.  Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL.

Authors:  Kevin J Curran; Steven P Margossian; Nancy A Kernan; Lewis B Silverman; David A Williams; Neerav Shukla; Rachel Kobos; Christopher J Forlenza; Peter Steinherz; Susan Prockop; Farid Boulad; Barbara Spitzer; Maria I Cancio; Jaap Jan Boelens; Andrew L Kung; Yasmin Khakoo; Victoria Szenes; Jae H Park; Craig S Sauter; Glenn Heller; Xiuyan Wang; Brigitte Senechal; Richard J O'Reilly; Isabelle Riviere; Michel Sadelain; Renier J Brentjens
Journal:  Blood       Date:  2019-12-26       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.